Every category where a model named iubenda for a mid-market B2B company. Share is first choices across the direct, paraphrase, budget and scale prompts; rank is within every product named in that category.

Category	Function	Share	Rank	Negative rate	Labels	Quadrant
Consent and privacy management	GTM data and infrastructure	6%	5 of 39	9%	23	accepted challenger

Movement

This is the first edition on this tier, so no move can be computed for iubenda yet. The next is due October 1, 2026. From the next edition this section shows, per buyer segment, whether its share moved by more than the measured noise floor.

By model

How each model treated iubenda across every prompt where it was named for a mid-market B2B company. Twelve models, six prompts per category.

Model	First choice	Alternative	Mention	Negative	Labels
Claude Haiku 4.5	1	1	1	0	3
GPT-5.4 mini	1	0	0	0	1
Gemini 3.5 Flash	0	1	0	0	1
Perplexity Sonar	0	1	0	0	1
Grok 4.1 Fast	0	0	1	1	2
Mistral Small	0	1	0	1	2
DeepSeek V4 Flash	0	2	1	0	3
Llama 4 Maverick	0	0	1	0	1
Qwen 3.7 Flash	1	1	1	0	3
Kimi K2	0	3	0	0	3
GLM 4.7 FlashX	0	0	1	0	1
MiniMax M2.5	0	2	0	0	2

By framing

Which of the six questions produced the naming. By model says how often; this says asked what. The first-choice count on the right carries the marks of the models that produced it.

FramingLabels by classFirst choices

Direct6 labels1

Paraphrase8 labels4

Comparative15 labelsNone

Budget-constrained9 labels1

Scale-constrained3 labels2

Negative9 labels1not counted in share

First choiceAlternativeMentionNegative50 labels in all, every segment counted; 8 of the 9 first choices count toward share, since the comparative and negative framings do not. The bar is one segment per label class, to scale within the framing.

What the models said for it

Verbatim evidence the judge attached to positive labels.

“I'd generally recommend iubenda if you want cookie consent plus broader privacy compliance in one platform” GPT-5.4 mini · Consent · paraphrase prompt · first choice

“My Top Pick for Mid-Sized B2B: Iubenda is often the "sweet spot."” Qwen 3.7 Flash · Consent · paraphrase prompt · first choice

“## Top Recommendation: iubenda” Claude Haiku 4.5 · Consent · paraphrase prompt · first choice

“Choose iubenda if you have a tiny budget ($7/mo) but also need professional, legally compliant Privacy and Terms” Gemini 3.5 Flash · Consent · budget prompt · alternative

And against it

Verbatim evidence attached to negative labels. A warning on a product with few labels is a warning; on a product with many, it is one voice among them.

“good add-on docs, but scales poorly multi-domain” Grok 4.1 Fast · Consent · paraphrase prompt · soft negative

“iubenda - Uses US cloud services” Mistral Small · Consent · negative prompt · soft negative

Named alongside

The products named in the same answers as iubenda, over the 50 answers that named it. Took the first choice instead counts the answers where the other product was the first choice and iubenda was named but was not.

ProductSame answerTook the first choice insteadHead to head

CookieYes40 of 5016Not in the top three

Cookiebot40 of 506Not in the top three

OneTrust35 of 504Not in the top three

Osano29 of 501Not in the top three

Enzuzo25 of 501Not in the top three

Termly24 of 504Not in the top three

Usercentrics21 of 501Not in the top three

Didomi19 of 500Not in the top three

TrustArc18 of 500Not in the top three

Complianz17 of 501Not in the top three

A head-to-head page exists where both products are in a category's top three. The other rows are the same fact without a page behind them, so they link to the product instead.

What carried it into the answer

The sites and pages cited by the answers that named iubenda. A fact about retrieval, not a lever on the model.

Citations exist only for the models that return a source list, four of the twelve in this edition, so these counts come from 10 of the 50 answers that named iubenda and are not a share of its labels.

Domains cited

iubenda.comYour site8

enzuzo.com6

didomi.io4

osano.com4

secureprivacy.ai4

usercentrics.com4

comparitech.com3

consently.net3

cookie-script.com3

elementor.com3

Thirty-four of the forty-two domain citations in answers naming iubenda came from somebody else's page.

Pages cited

enzuzo.com/blog/best-consent-management-platforms6

iubenda.com/en/blog/best-consent-management-platform5

didomi.io/blog/top-10-best-consent-management-platforms-cmp4

osano.com/comparison/consent-management-platform4

comparitech.com/data-privacy-management/best-consent-management-platforms3

expertinsights.com/compliance/the-top-consent-management-solutions3

secureprivacy.ai/blog/best-cmp-20263

usercentrics.com/knowledge-hub/consent-management-platforms3

Pages are listed as the models cited them.

Names read as iubenda

What the judge wrote, as written, with how often. The vendor table decides that these count as iubenda; a claim can dispute any of them.

Iubenda 1

The company

iubenda.

Website: iubenda.com
Headquarters: Italy

From Wikidata, fetched September 14, 2026. These describe the company, not the product's standing, and a claimed page can dispute any of them. · Wikidata

Is this your product?

Claim this page

Claiming is free and changes nothing in the data. A claimed page shows a verified contact who is told when each edition publishes and when iubenda's standing changes by more than the noise floor; the right to propose corrections to the vendor table, meaning names the judge wrote that should or should not read as iubenda, applied by version and listed in the change log; and a one-line description supplied by the vendor and marked as such.

It does not get any change to labels, shares or verdicts, any preview, or any say over which quotes appear. A verification link goes to your work email; an address at iubenda.com is approved on the spot, any other address is reviewed by hand.

Your name and company appear on the claimed page, or the company alone if you ask below. A title and a LinkedIn address appear there too if you give them, and are left off if you do not. Your email address is never published.